← Search

Omics · study · 2026

Combinatorial E2F knockdown in the prostate cancer PM154 cell line

Listed in NCBI GEO

Treatment-emergent neuroendocrine prostate cancer (CRPC-NE) arises through RB1 loss and lineage plasticity in response to androgen receptor-targeted therapies, creating constitutive E2F transcription factor addiction that lacks effective therapeutic exploitation.

Description

All six E2F family members harbour a conserved U12-type minor intron within their dimerisation domain — processed exclusively by the minor spliceosome — creating a single post-transcriptional node whose inhibition simultaneously targets the entire activator E2F programme.

Combinatorial E2F knockdown RNA-seq revealed E2F3 as the dominant activator E2F and uncovered a paradoxical dual role for the E2F family as gatekeepers of neuroendocrine identity — complete E2F depletion unleashing an ASCL1-driven differentiation programme resembling pancreatic beta cell specification.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 65%
Provenance · 1 source records, 9 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34690215 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title